Company intelligence / Profile preview

assisTek

Doylestown, Pennsylvania, United States

Ownership: Private
Employees: ~70
Development stage: Other

Overview

assisTek provides eSource solutions and a customizable electronic clinical outcome assessment (eCOA) platform supporting data collection for decentralized and site-based clinical trials. The platform has been deployed in over 500 clinical trials, supporting more than 90 languages in 80 countries and across 46 therapeutic areas, with broad adoption in studies for rare and ultra-rare diseases. The company is not a drug developer and does not report clinical results.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaboration with a California health technology company to integrate ECG/EKG capabilities

Beyond the preview

Go deeper on assisTek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on assisTek.

Explore the full profile